European Archives - Page 69 of 1095 - European Medical Journal

EMJ Neurology 13 [Supplement 3] 2025

This article describes a recently initiated Phase II trial of a novel anti-tau monoclonal antibody, BMS-986446, the design for which was…

Handshake on a green background

Novartis to acquire Anthos Therapeutics for $925m

To boost its cardiovascular pipeline, Novartis has announced the acquisition of the company it co-founded with Blackstone Life Sciences.

Unveiling the Overlap: Cardiac Sarcoidosis and Arrhythmogenic Cardiomyopathy

Study reveals distinct clinical features in patients with both cardiac sarcoidosis and ACM-associated genetic variants, aiding diagnosis.

Rising Incidence of Late-Stage Prostate Cancer in America

These findings suggest that the reduction in PSA screening has had a widespread impact.

Air Pollution Fuels Respiratory Infection Hospitalisations

A large-scale study has revealed a significant association between long-term air pollution exposure and hospital admissions for acute lower respiratory infections in adults.

Martin Price, J&J

J&J’s Martin Price on World Cancer Day 2025 – Part 2

Uncover more of Martin Price, Vice President, Health Economics, Market Access and Reimbursement, EMEA, Johnson & Johnson’s thoughts on the oncology space

AI Enhances Breast Cancer Screening by Identifying High-Risk Women for MRI

AI proves useful in enhancing breast cancer screening for high-risk women.

Coronary Events After TAVR: Key Findings from the France-TAVI Registry

Coronary events post-TAVR are uncommon but serious. Patients undergoing PCI have better outcomes, especially with balloon-expandable valves.

Increased Cancer Risk After Cerebral Venous Thrombosis

CVT patients face a significantly higher cancer risk, especially in the first year and up to 10 years after diagnosis.

High Discontinuation Rates of GLP-1 RAs Among Patients Without Type 2 Diabetes

Study finds that a significant proportion of adults prescribed GLP-1 RAs for weight management discontinue treatment within a year.